ainos.com (AIMD) Price-to-Projected Revenue Ratio

Ainos, Inc. (AIMD) is implementing AI algorithms for the instantaneous analysis of biomaterials to eliminate human error. The forward P/S trend reflects the dynamics of this automation, where the value of 899.50 serves as the current metric. Management is developing cloud monitoring and portable diagnostic systems. The strategy is based on B2B integration of patents into electronics, deliberately avoiding mergers and acquisitions.

AIMD Ainos: Market Cap to Future Revenue Ratio in the range 04/28/2023 - 11/14/2026

Comprehensive metric breakdowns and analytics for Ainos, Inc. (AIMD)

- current price and projected stock value:

Stock Price Ainos Corporation|AIMD - Analyst Median Target

- market capitalization details:

Market Value Ainos Corp|AIMD - Business Value

- book value of equity indicators:

Net Assets per Single Share Ainos|AIMD - Total Stockholders' Equity|Market Value to Book Value Ratio ainos.com|AIMD - Company Total Asset Base

- company total debt and liquidity indicators:

- business earnings and investment ratios data:

AIMD - Net Financial Result|Projected Future Earnings Ainos, Inc.|AIMD - P/E Multiple|Forward P/E Multiple ainos.com|AIMD - Growth-Adjusted Market Cap to Net Income|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Ainos Inc|AIMD - Operating profit before deduction of amortization|Net earnings per share (EPS TTM) Ainos|AIMD - Earnings per share for the last 12 months|Year-over-year earnings per share growth for the last twelve months ainos.com|AIMD - Net earnings per share growth this year|Earnings growth forecast for next year Ainos, Inc.

- revenue and sales details:

AIMD - Company Total Revenue|Projected Sales Volume Ainos, Inc.|AIMD - Market Cap to Revenue Ratio|Forward P/S Multiple Ainos

Comprehensive company analysis:AIMD (Ainos, Inc.)

Manufactured products of Ainos Corporation

The integration of diagnostic platforms into pharmacy chains provides Ainos, Inc. (AIMD) with strategic access to the rapid testing market. The forward P/S ratio quantifies this expansion by comparing market capitalization with expected revenue to assess the premium paid for future growth. Low indicator values on this chart may suggest business maturity, whereas high values confirm market confidence in the issuer's technological potential.

Competitor analysis for Ainos, Inc.

Forward P/S Multiple A (agilent.com)|Quest Corp (DGX) - Market Cap to Future Revenue Ratio|ILMN - Price-to-Projected Revenue Ratio|EXAS - Forward P/S Multiple|RVTY (Revvity) - Forward Price-to-Revenue Multiple|Bio-Rad - Forward Price to Sales|Price-to-Projected Revenue Ratio anbio.com|Forward P/S Multiple Sotera Health Company|Price-to-Projected Revenue Ratio QuidelOrtho (QDEL)|OPK - Market Cap to Future Revenue Ratio|caredx.com - Forward Price-to-Revenue Multiple|Market Cap to Expected Sales Ratio Maravai LifeSciences Corp (MRVI)|FLGT: Forward Price-to-Revenue Multiple|Forward Price to Sales LAB (Fluidigm)|Cytek Biosciences Inc (CTKB) - Price-to-Projected Revenue Ratio|OSUR: Price to Expected Revenue Ratio|Forward Price-to-Revenue Multiple XGN|MDXH: Forward Price to Sales|Price-to-Projected Revenue Ratio Lucid Diagnostics Inc. (LUCD)|Price-to-Projected Revenue Ratio PRE (Prenetics Global Limited)|Forward P/S Multiple IMDX (Insight Molecular Diagnostics Inc)|Price to Expected Revenue Ratio TRIB (Trinity Biotech Corp)|PRPH - Price-to-Projected Revenue Ratio|Co-Diagnostics Inc (CODX) - Forward Price-to-Revenue Multiple|HSCS: Forward P/S Multiple|BMRA - Market Cap to Expected Sales Ratio|Forward Price-to-Revenue Multiple CDIO|Market Cap to Future Revenue Ratio onconetix.gcs-web.com ONCO|Price-to-Projected Revenue Ratio Virax Biolabs (VRAX)|Price to Expected Revenue Ratio BJDX|Price-to-Projected Revenue Ratio Vermillion AWH|Accelerate Diagnostics Inc (AXDX) - Market Cap to Future Revenue Ratio|centogene.com - Forward P/S Multiple|ENZ (Enzo Biochem Inc.) - Market Cap to Projected Revenue|Market Cap to Future Revenue Ratio FRES|Market Cap to Future Revenue Ratio GTG Labs (GENE)|ME (23andme.com) - Forward P/S Multiple|Forward P/S Multiple Psychemedics Inc